Accelerate the development of high-performance
antigen tests

The ReadyDetect: Next-Generation Diagnostics Competition is a $10 million, 2-part competition to advance high-performance testing and expand low-cost diagnostics into the home or in the field. I-CREATE, in partnership with the Biomedical Advanced Research and Development Authority (BARDA), calls on diagnostics researchers and developers worldwide to partner and accelerate the development of high-performance antigen tests that can be applied to the detection of key pathogens on PHEMCE’s high priority threats list.

All winners expected to be announced by Spring 2028

An expert judging panel will evaluate submissions using Concept Stage criteria and recommend up to 10 winners for the Antigen Product Prize. Each winner will receive $100,000 from the $1M Concept Stage prize pool.

At the Prototype Stage, the panel will recommend the first submissions that meet the criteria. Up to 3 winners may each receive a $3M award.